Using Substances to Cope With the COVID-19 Pandemic: U.S. National Data at Age 19 Years

To examine predictors of using substances to cope with the COVID-19 pandemic, including pandemic-related isolation, stress, economic hardship, demographics, and prepandemic substance use. A U.S. national sample (N = 1,244) was followed from the 12th grade in Spring 2019 to Fall 2020 (M = 19.6 years)...

Full description

Saved in:
Bibliographic Details
Published inJournal of adolescent health Vol. 70; no. 2; pp. 340 - 344
Main Authors Patrick, Megan E., Parks, Michael J., Fairlie, Anne M., Kreski, Noah T., Keyes, Katherine M., Miech, Richard
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2022
Elsevier BV
Society for Adolescent Health and Medicine. Published by Elsevier Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To examine predictors of using substances to cope with the COVID-19 pandemic, including pandemic-related isolation, stress, economic hardship, demographics, and prepandemic substance use. A U.S. national sample (N = 1,244) was followed from the 12th grade in Spring 2019 to Fall 2020 (M = 19.6 years) when young adults were asked about their use of marijuana, vaping, drinking, and other drugs to cope. In Fall 2020, 15.7% reported using marijuana, 8.9% increased vaping, and 8.2% increased drinking to cope with social distancing and isolation. In multivariable analyses controlling for demographics and prepandemic substance use, COVID-related isolation was associated with marijuana use (odds ratio = 1.31, 95% confidence interval = 1.06–1.63) and economic hardship with increased drinking (odds ratio = 1.39, 95% confidence interval = 1.01–1.92). There were few demographic differences. Most (>80%) who reported COVID-related substance use coping used that substance before pandemic. Young people reported using substances to cope with the COVID-19 pandemic, especially if they reported prepandemic use.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1054-139X
1879-1972
1879-1972
DOI:10.1016/j.jadohealth.2021.11.006